AR011964A1 - Un compuesto derivado de (1h-indol-2-il)-5-[(2h-pirrol-2-ilideno)metil]-1h- pirrol, su utilizacion, un procedimiento para producirlo, productos ycomposiciones farmaceuticas que comprenden a dicho compuesto, un compuesto util como intermediario para preparar a dicho compuesto y una preparacion de - Google Patents
Un compuesto derivado de (1h-indol-2-il)-5-[(2h-pirrol-2-ilideno)metil]-1h- pirrol, su utilizacion, un procedimiento para producirlo, productos ycomposiciones farmaceuticas que comprenden a dicho compuesto, un compuesto util como intermediario para preparar a dicho compuesto y una preparacion deInfo
- Publication number
- AR011964A1 AR011964A1 ARP980101075A ARP980101075A AR011964A1 AR 011964 A1 AR011964 A1 AR 011964A1 AR P980101075 A ARP980101075 A AR P980101075A AR P980101075 A ARP980101075 A AR P980101075A AR 011964 A1 AR011964 A1 AR 011964A1
- Authority
- AR
- Argentina
- Prior art keywords
- compound
- alkyl
- alkoxy
- pirrol
- substituted
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 8
- 238000000034 method Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 title 1
- -1 nitro, hydroxy Chemical group 0.000 abstract 5
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 3
- 229910052736 halogen Inorganic materials 0.000 abstract 3
- 150000002367 halogens Chemical group 0.000 abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 125000005116 aryl carbamoyl group Chemical group 0.000 abstract 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 150000002431 hydrogen Chemical group 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 125000003837 (C1-C20) alkyl group Chemical group 0.000 abstract 1
- MWLCANHMIJFNDV-UHFFFAOYSA-N 2-[2-(pyrrol-2-ylidenemethyl)pyrrol-1-yl]-1h-indole Chemical group C=1C=CN(C=2NC3=CC=CC=C3C=2)C=1C=C1C=CC=N1 MWLCANHMIJFNDV-UHFFFAOYSA-N 0.000 abstract 1
- 208000009746 Adult T-Cell Leukemia-Lymphoma Diseases 0.000 abstract 1
- 206010001413 Adult T-cell lymphoma/leukaemia Diseases 0.000 abstract 1
- 125000003358 C2-C20 alkenyl group Chemical group 0.000 abstract 1
- 229910003827 NRaRb Inorganic materials 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000003806 alkyl carbonyl amino group Chemical group 0.000 abstract 1
- 125000005196 alkyl carbonyloxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000004104 aryloxy group Chemical group 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 125000001589 carboacyl group Chemical group 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 230000002519 immonomodulatory effect Effects 0.000 abstract 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Transplantation (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Pyrrole Compounds (AREA)
Abstract
Un compuesto que es un derivado de (1H-indol-2-il)-5-[(2H-pirrol-2-ilideno) metil]-1H-pirrol de la formula (I), donde cada una de R1, R2, R3 y R4, quepueden ser iguales o diferentes, representan, de manera independiente, hidrogeno, alquilo C1-C6, halogeno, ciano, nitro, hidroxi, alcoxi C1-C6insustituido o sustituido por fenilo, alquilo C1-C6-carboniloxi, -NRaRb donde cada una de Ra y Rb son, de manera independiente, hidrogeno o alquilo C1-C6,alquilo C1-C6-carbonilamino, carboxi, (alcoxi C1-C6)carbonilo, aralquil carbamoilo, arilcarbamoilo, o -CONRcRd donde cada una de Rc y Rd son, demanera independiente, hidrogeno o alquilo C1-C6 o, Rc y Rd, tomadas en forma conjunta con el átomo de nitrogeno al que se encuentran ligadas, forman unanillo de morfolino o piperidino; R5 representa halogeno, hidroxi o alcoxi C1- C11 insustituido o sustituido por fenilo; y R6 representa hidrogeno, alcanoiloC2-C20, alquenoilo C3-C20, fenilo, alquilo C1-C20 o alquenilo C2-C20, donde losgrupos alcanoilo, alquenoilo, alquilo y alquenilo se encuentran insustituidoso sustituidos por entre 1 y 3 sustituyentes que se seleccionan, de manera independiente, entre halogeno, alcoxi C1-C6, hidroxi, arilo, ariloxi, ciano,carboxi, (alcoxiC1-C6)carbonilo, (alquenilo C3-C4)carbamoilo, aralquil carbamoilo, arilcarbamoilo y -CONRcRd donde Rc y Rd son tal como se lasdefiniera antes; o una sal farmacéuticamente aceptable del mismo. Resulta util como un agente inmunomodulador comotambién para llevar a cabo el tratamientode leucemia-linfoma de células T adultas. Su utilizacion, un procedimiento para producirlo, productos y composiciones farmacéuticas que comprenden a estecompuesto, un compuesto util como intermediario para preparar a este compuesto y una preparacion de combinacion que comprende un agente
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9705035.5A GB9705035D0 (en) | 1997-03-11 | 1997-03-11 | Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR011964A1 true AR011964A1 (es) | 2000-09-13 |
Family
ID=10809054
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980101075A AR011964A1 (es) | 1997-03-11 | 1998-03-11 | Un compuesto derivado de (1h-indol-2-il)-5-[(2h-pirrol-2-ilideno)metil]-1h- pirrol, su utilizacion, un procedimiento para producirlo, productos ycomposiciones farmaceuticas que comprenden a dicho compuesto, un compuesto util como intermediario para preparar a dicho compuesto y una preparacion de |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6071947A (es) |
| EP (1) | EP0909271B1 (es) |
| JP (1) | JP2000510873A (es) |
| KR (1) | KR20000010913A (es) |
| CN (1) | CN1089763C (es) |
| AR (1) | AR011964A1 (es) |
| AT (1) | ATE206118T1 (es) |
| AU (1) | AU740583B2 (es) |
| BR (1) | BR9805938A (es) |
| CA (1) | CA2253588A1 (es) |
| DE (1) | DE69801795T2 (es) |
| DK (1) | DK0909271T3 (es) |
| EA (1) | EA001055B1 (es) |
| ES (1) | ES2165150T3 (es) |
| GB (1) | GB9705035D0 (es) |
| HU (1) | HUP0003614A3 (es) |
| IL (1) | IL126839A (es) |
| MY (1) | MY117159A (es) |
| NO (1) | NO316754B1 (es) |
| NZ (1) | NZ333015A (es) |
| PL (1) | PL329808A1 (es) |
| PT (1) | PT909271E (es) |
| TW (1) | TW568911B (es) |
| UA (1) | UA56169C2 (es) |
| WO (1) | WO1998040380A1 (es) |
| ZA (1) | ZA981976B (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2289549A3 (en) | 1999-10-01 | 2011-06-15 | Immunogen, Inc. | Immunoconjugates for treating cancer |
| US20040014987A1 (en) | 2000-01-26 | 2004-01-22 | Gemin X Biotechnologies Inc. | Pyrrole-Type compounds, compositions, and methods for treating cancer or viral diseases |
| US6407244B1 (en) | 2000-01-26 | 2002-06-18 | Gemin X Biotechnologies Inc. | Pyrrole-type compounds, compositions, and methods for treating cancer or viral diseases |
| DE10038699A1 (de) * | 2000-07-31 | 2002-02-14 | Michael Sittinger | Mittel zur Verringrung der Abstoßungsreaktionen bei Transplantaten |
| ATE378329T1 (de) | 2001-07-18 | 2007-11-15 | Gemin X Biotechnologies Inc | Verbindungen vom pyrroltyp, zusammensetzungen und verfahren zur behandlung von krebs, zur behandlung von virenerkrankungen und zur unterdrückung der immunreaktion |
| AU2003207774A1 (en) * | 2002-01-30 | 2003-09-02 | Montana State University | Pestalotiopsis microsporia isolates and compounds derived therefrom |
| US7968569B2 (en) * | 2002-05-17 | 2011-06-28 | Celgene Corporation | Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| KR101168441B1 (ko) * | 2003-05-30 | 2012-07-25 | 게민 엑스 파마슈티컬스 캐나다 인코포레이티드 | 암 또는 바이러스 질환의 치료를 위한 삼복소환 화합물,조성물 및 방법 |
| EP1768662A2 (en) | 2004-06-24 | 2007-04-04 | Novartis Vaccines and Diagnostics, Inc. | Small molecule immunopotentiators and assays for their detection |
| US8420693B2 (en) * | 2004-12-28 | 2013-04-16 | Gemin X Pharmaceuticals Canada Inc. | Dipyrrole compounds, compositions, and methods for treating cancer or viral diseases |
| EP1853255A4 (en) * | 2005-02-22 | 2009-07-08 | Gemin X Pharmaceuticals Canada | METHOD FOR TREATING ARTHRITIS WITH TRIHETEROCYCLIC COMPOUNDS |
| DE102005025225A1 (de) | 2005-06-01 | 2006-12-07 | Sanofi-Aventis Deutschland Gmbh | Verfahren zur Herstellung von 2-(2-Amino-pyrimidin-4-yl)-1H-indol-5-carbonsäure-derivaten |
| US20080051400A1 (en) * | 2006-07-06 | 2008-02-28 | Gemin X Biotechnologies Inc. | Methods for treating or preventing anemia or thrombocytopenia using a triheterocyclic compound |
| CN113845524B (zh) * | 2021-10-29 | 2023-11-07 | 四川农业大学 | 一种螺吡咯吲哚酮类化合物及其制备方法和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61280429A (ja) * | 1985-06-06 | 1986-12-11 | Chugai Pharmaceut Co Ltd | 免疫抑制剤 |
| HUT73807A (en) * | 1993-04-22 | 1996-09-30 | Pfizer Res & Dev | 5-ht1-like indole derivatives and pharmaceutical compositions containing them |
| GB9326284D0 (en) * | 1993-12-23 | 1994-02-23 | Erba Carlo Spa | Pyrrolydenemethyl-derivatives and process for their preparation |
| GB9603212D0 (en) * | 1996-02-15 | 1996-04-17 | Pharmacia Spa | Process for the preparation of 2,2'-bipyrrolyl-pyrromethane derivatives |
-
1997
- 1997-03-11 GB GBGB9705035.5A patent/GB9705035D0/en active Pending
-
1998
- 1998-02-27 AU AU68283/98A patent/AU740583B2/en not_active Ceased
- 1998-02-27 AT AT98913665T patent/ATE206118T1/de not_active IP Right Cessation
- 1998-02-27 US US09/147,249 patent/US6071947A/en not_active Expired - Fee Related
- 1998-02-27 EA EA199801004A patent/EA001055B1/ru not_active IP Right Cessation
- 1998-02-27 ES ES98913665T patent/ES2165150T3/es not_active Expired - Lifetime
- 1998-02-27 DE DE69801795T patent/DE69801795T2/de not_active Expired - Fee Related
- 1998-02-27 CA CA002253588A patent/CA2253588A1/en not_active Abandoned
- 1998-02-27 IL IL12683998A patent/IL126839A/en not_active IP Right Cessation
- 1998-02-27 UA UA98126509A patent/UA56169C2/uk unknown
- 1998-02-27 PT PT98913665T patent/PT909271E/pt unknown
- 1998-02-27 PL PL98329808A patent/PL329808A1/xx unknown
- 1998-02-27 WO PCT/EP1998/001285 patent/WO1998040380A1/en not_active Ceased
- 1998-02-27 CN CN98800469A patent/CN1089763C/zh not_active Expired - Fee Related
- 1998-02-27 JP JP10539188A patent/JP2000510873A/ja not_active Withdrawn
- 1998-02-27 KR KR1019980709060A patent/KR20000010913A/ko not_active Abandoned
- 1998-02-27 NZ NZ333015A patent/NZ333015A/xx unknown
- 1998-02-27 HU HU0003614A patent/HUP0003614A3/hu unknown
- 1998-02-27 EP EP98913665A patent/EP0909271B1/en not_active Expired - Lifetime
- 1998-02-27 BR BR9805938-6A patent/BR9805938A/pt not_active IP Right Cessation
- 1998-02-27 DK DK98913665T patent/DK0909271T3/da active
- 1998-03-07 TW TW087103345A patent/TW568911B/zh active
- 1998-03-09 ZA ZA981976A patent/ZA981976B/xx unknown
- 1998-03-11 MY MYPI98001060A patent/MY117159A/en unknown
- 1998-03-11 AR ARP980101075A patent/AR011964A1/es unknown
- 1998-11-10 NO NO19985248A patent/NO316754B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0909271A1 (en) | 1999-04-21 |
| DE69801795T2 (de) | 2002-05-23 |
| EA199801004A1 (ru) | 1999-06-24 |
| CA2253588A1 (en) | 1998-09-17 |
| IL126839A (en) | 2002-12-01 |
| IL126839A0 (en) | 1999-09-22 |
| CN1222911A (zh) | 1999-07-14 |
| GB9705035D0 (en) | 1997-04-30 |
| TW568911B (en) | 2004-01-01 |
| NO985248D0 (no) | 1998-11-10 |
| US6071947A (en) | 2000-06-06 |
| NO316754B1 (no) | 2004-04-26 |
| CN1089763C (zh) | 2002-08-28 |
| ZA981976B (en) | 1998-09-09 |
| KR20000010913A (ko) | 2000-02-25 |
| WO1998040380A1 (en) | 1998-09-17 |
| HUP0003614A3 (en) | 2003-04-28 |
| JP2000510873A (ja) | 2000-08-22 |
| ES2165150T3 (es) | 2002-03-01 |
| AU6828398A (en) | 1998-09-29 |
| PT909271E (pt) | 2002-03-28 |
| HUP0003614A2 (hu) | 2001-10-28 |
| ATE206118T1 (de) | 2001-10-15 |
| EA001055B1 (ru) | 2000-08-28 |
| AU740583B2 (en) | 2001-11-08 |
| EP0909271B1 (en) | 2001-09-26 |
| DE69801795D1 (de) | 2001-10-31 |
| NZ333015A (en) | 2000-04-28 |
| PL329808A1 (en) | 1999-04-12 |
| UA56169C2 (uk) | 2003-05-15 |
| DK0909271T3 (da) | 2002-01-28 |
| MY117159A (en) | 2004-05-31 |
| BR9805938A (pt) | 1999-08-31 |
| NO985248L (no) | 1999-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR011964A1 (es) | Un compuesto derivado de (1h-indol-2-il)-5-[(2h-pirrol-2-ilideno)metil]-1h- pirrol, su utilizacion, un procedimiento para producirlo, productos ycomposiciones farmaceuticas que comprenden a dicho compuesto, un compuesto util como intermediario para preparar a dicho compuesto y una preparacion de | |
| HUP0300207A2 (en) | 1,2,3,4-tetrahydroisquinoline derivatives, pharmaceutical compositions containing them and their preparation processes | |
| HUP0303756A2 (hu) | 1-Aril- vagy 1-alkilszulfonil-heterociklobenzazolok és eljárás ezek elõállítására és ezeket tartalmazó gyógyszerkészítmények | |
| RU95108329A (ru) | Замещенные производные тиазолидиндиона, способ их получения, фармкомпозиция | |
| UY26143A1 (es) | Derivados heterocíclicos útiles como agentes anticancerosos | |
| HUP0300203A2 (en) | Novel cyclic amide derivatives, and pharmaceutical compositions containing same | |
| HUT62873A (en) | Process for producing alkoxy-substituted taxane derivatives and pharmaceutical compositions comprising same as active ingredient | |
| HUP0302380A2 (hu) | Cisztein-proteázok reverzibilis inhibitoraiként alkalmazható új spiroheterociklusos vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| SV2003001494A (es) | Derivados de aminoindazoles, procedimiento de su preparacion e intermedios de dicho procedimiento titulo de medicamentos y composiciones farmaceuticas que los contienen | |
| CO5550421A2 (es) | Derivados de indol utiles para el tratamiento de enfermeda- des | |
| ATE225782T1 (de) | Benzopyranderivate | |
| AR004195A1 (es) | Nuevos derivados de la 5-0 desosaminil-6-0-metil-eritronolida a, su procedimiento de preparacion, compuestos intermediarios, metodo de aplicacionde los mismos para la preparacion de productos biologicamente activos. | |
| ES2140961T3 (es) | Nuevos derivados de 19-nor-pregneno. | |
| CA2280905A1 (en) | Highly lipophilic camptothecin derivatives | |
| NZ307505A (en) | Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds | |
| CY1116183T1 (el) | Πιπεραζινοδιονες ως ανταγωνιστες υποδοχεα οξυτοκινης | |
| AR020032A1 (es) | Derivados de 1,3 -metil eritromicina. | |
| HUP0102466A2 (hu) | Antiösztrogén hatású új benzo-pirán vagy tiobenzo-pirán származékok, eljárás előállításukra és azokat tartalmazó gyógyszerkészítmények | |
| BG104287A (en) | Halogensubstituted tetracyclic derivatives of tetrahydrofuran | |
| AR006719A1 (es) | Derivados de bencilamina y formulacion farmaceutica que comprende a uno de dichos derivados. | |
| DK81885D0 (da) | Pyrido-benzothiazinderivater, fremgangsmaade til fremstilling deraf ogfarmaceutisk praeparat indeholdende mindst et saadant derivat | |
| FR2721608B1 (fr) | Dérivés de thiazolidine, leur préparation et les médicaments les contenant. | |
| AR007108A1 (es) | Agentes antitumorales y antivirales alquilantes, procedimiento para su preparacion, utilizacion de los mismos para la fabricacion de un medicamento y composicion farmaceutica que contiene a dichos agentes. | |
| PE20021018A1 (es) | DERIVADOS DE ß - CARBOLINA | |
| HUP0000321A2 (hu) | NOS inhibitor hatású aromás aminszármazékok, eljárás előállításukra, valamint a vegyületeket tartalmazó gyógyszerkészítmények |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |